ArticleFrontiers in immunology2022

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors.

Min Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.